Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2012
10/04/2012US20120252740 Hdac inhibitors and therapeutic methods of using same
10/04/2012US20120251491 Fused tricyclic aryl compounds useful for the treatment of viral diseases
10/04/2012CA2831716A1 Compounds for treatment of metabolic syndrome
10/04/2012CA2831356A1 Imidazo [1,2-a]pyridine_compounds for use in therapy
10/04/2012CA2830148A1 Novel furanone derivatives
10/04/2012CA2830027A1 Novel bicyclic pyridinones
10/03/2012EP2505588A1 Process for preparing aminomethyl azaadamantane derivatives as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (NNRS)
10/03/2012EP2504338A1 Pyridine-pyridinone derivatives, preparation and therapeutic use thereof
10/03/2012EP2504337A1 Novel polymorphic shapes of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-5-yl)carbamate
10/03/2012EP2504336A1 Novel naphthyridine derivatives and the use thereof as kinase inhibitors
10/03/2012EP2504335A2 Method for producing methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl} carbamate and its purification for use thereof as pharmaceutical substance
10/03/2012EP2504334A2 Method for producing methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate and its purification for use thereof as pharmaceutical substance
10/03/2012EP2504317A1 Potassium channel modulators
10/03/2012EP2504316A1 Heterocylic compounds as antagonists of the orexin receptors
10/03/2012EP2504010A1 Fused bicyclic pyrimidine derivatives and methods of use thereof
10/03/2012EP2503890A1 Azabenzimidazoles as fatty acid synthase inhibitors
10/03/2012EP2503881A1 Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
10/03/2012CN102714276A Organic semiconductor material, organic semiconductor thin film, and organic thin film transistor
10/03/2012CN102712657A Antimicrobial compounds and methods of making and using the same
10/03/2012CN102712641A MK2 inhibitors
10/03/2012CN102712640A Tricyclic heterocyclic compounds, compositions and methods of use thereof
10/03/2012CN102712639A Compound having a substituted anthracene ring structure and pyridoindole ring structure, and organic electroluminescent element
10/03/2012CN102712638A New phenylhydrazone derivatives and their use as pharmaceuticals
10/03/2012CN102712637A Method for producing methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl} carbamate and its purification for use thereof as pharmaceutical substance
10/03/2012CN102712636A Compounds and compositions as TLR activity modulators
10/03/2012CN102712635A 1h-pyrazolo [3,4-b] pyridine compounds for inhibiting RAF kinase
10/03/2012CN102712624A Indole compound and pharmaceutical use thereof
10/03/2012CN102712623A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
10/03/2012CN102712601A A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
10/03/2012CN102711473A Bruton's tyrosine kinase inhibitors
10/03/2012CN102702269A Carbazole group-containing bipyridino [3, 2-a:2', 3'-c] phenazine tricarbonyl rhenium (I) complexes, preparation method and application thereof
10/03/2012CN102702197A Olprinone hydrochloride derivative and preparation method thereof
10/03/2012CN102702196A Method for synthesizing 3-methyl-7-diazaindene
10/03/2012CN102702195A Use of novel compound having affinity for amyloid, and process for production of the same
10/03/2012CN102702194A Anti-viral compounds
10/03/2012CN102702193A Anti-viral compounds
10/03/2012CN102702147A Andrographolide analogue and application of andrographolide analogue to treatment
10/03/2012CN102702064A 2,4,6-phenylsubstituierte cyclische ketoenole
10/03/2012CN102060856B Method for extracting tabersonine from voacanga seeds
10/03/2012CN101945870B 5-anilinoimidazopyridines and methods of use
10/03/2012CN101508893B 1,4,5,8-naphthalenetetracarboxylic imide derivative bifluorescent material and method of preparing the same
10/02/2012US8278452 Heterocyclic compounds and compositions as c-kit and PDGFR kinase inhibitors
10/02/2012US8278450 Kinase inhibitors
10/02/2012US8278320 Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands
10/02/2012CA2709774C Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate
10/02/2012CA2690953C Benzimidazole derivatives
10/02/2012CA2685597C Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as p38 modulators, process for their preparation, and their pharmaceutical use
10/02/2012CA2565761C Substituted azaquinazolines having an antiviral action
10/02/2012CA2557752C Hydroxy-6-heteroaryl-phenanthridines and their use as pde4 inhibitors
09/2012
09/27/2012WO2012129344A1 Fused tricyclic dual inhibitors of cdk 4/6 and flt3
09/27/2012WO2012127885A1 Tetrahydrocarboline derivative
09/27/2012WO2012126390A1 Autophagy inducing compound and use thereof
09/27/2012WO2012126280A1 Rutaecarpine compound, preparation method therefor, and use thereof
09/27/2012WO2012126275A1 Spiro-containing dihydropyrazole compounds
09/27/2012WO2012126084A1 Hsp-90 binding compounds, compositions thereof, and their use iν the treatment and prevention of fungal infections
09/27/2012WO2012065963A3 Antiviral condensed heterocyclic compounds
09/27/2012US20120245356 Process for the Preparation of Cycloheptapyridine CGRP Receptor Antagonists
09/27/2012US20120245347 Compounds and Derivatives of 2H-Pyrido (3,2-b)(1, 4) Oxazin 3)4H)-Ones as raf Kinase and LRRK2 Inhibitors
09/27/2012US20120245344 Gpr119 agonist
09/27/2012US20120245199 [4 [4-(aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1h-pyrrolo-pyridin-yl)-methanones and synthesis thereof
09/27/2012US20120245196 1-substituted 2-azabicyclo [3.1.1] heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders
09/27/2012US20120245190 Autophagy inducing compound and the uses thereof
09/27/2012US20120245187 Heterobicyclic carboxamides as inhibitors for kinases
09/27/2012US20120245178 Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
09/27/2012US20120245175 Mk2 inhibitors
09/27/2012US20120245174 Compounds and methods for kinase modulation, and indications therefor
09/27/2012US20120245171 Benzpyrazole derivatives as inhibitors of pi3 kinases
09/27/2012US20120245170 Pyrazolopyridine derivatives as anticancer agent
09/27/2012US20120245164 Diphenyl-pyrazolopyridine derivatives, preparation thereof, and use thereof as nuclear receptor not modulators
09/27/2012US20120245153 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
09/27/2012US20120245152 3-(biaryoxy)propionic acid derivative
09/27/2012US20120245149 NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS
09/27/2012US20120245140 N-containing heteroaryl derivatives as jak3 kinase inhibitors
09/27/2012US20120245138 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides
09/27/2012US20120245026 Spiro fused 1-amino - piperdine pyrrolidine dione derivatives with pesticidal activity
09/27/2012US20120244110 Fused tricyclic dual inhibitors of cdk 4/6 and flt3
09/27/2012US20120244081 Manganese chelates and their use as contrast agents in magnetic resonance imaging (mri)
09/27/2012CA2830516A1 Fused tricyclic dual inhibitors of cdk 4/6 and flt3
09/26/2012EP2502925A1 Pyridine imidazoles and aza-indoles as progesterone receptor modulators
09/26/2012EP2502624A1 Lonidamine analogues and their use in male contraception and cancer treatment
09/26/2012EP2501695A2 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
09/26/2012EP2501693A1 Novel heterocyclic acrylamides and their use as pharmaceuticals
09/26/2012EP2501685A1 [1,5]-diazocin derivatives
09/26/2012EP2501231A1 Quinolizidinone carboxamide m1 receptor positive allosteric modulators
09/26/2012CN1738618B Pharmaceutical compositions and uses thereof
09/26/2012CN102696128A Organic electroluminescent element and light-emitting polymer composition
09/26/2012CN102695708A N1-pyrazolospiroketone acetyl-coA carboxylase inhibitors
09/26/2012CN102695707A Compound and organic electroluminescent element using said compound
09/26/2012CN102695706A Imidazopyridine derivatives as JAK inhibitors
09/26/2012CN102695546A Heterocylcic derivatives as inhibitors of glutaminyl cyclase
09/26/2012CN102690265A 4-substituted azaadamantane derivatives and methods of use thereof
09/26/2012CN102690264A 2-phenyl-3-substituted-imidazo[1,2-a]pyridine derivatives and preparation method thereof
09/26/2012CN102690263A Enzymatic extraction process of swainsonine
09/26/2012CN102690262A Lead compound of targeting human La protein and purpose thereof in preparation of medicament for resisting hepatitis B virus
09/26/2012CN102127077B Method for preparing nevirapine
09/26/2012CN101838269B 1,3,8-triaza-spiro[4.5]decane-4-ketone compounds and pharmaceutical application thereof
09/26/2012CN101808992B 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
09/26/2012CN101781312B Method for synthesizing derivatives of quinoline or indole
09/26/2012CN101735217B Application of imidazole [4,5-f][1,10] phenanthroline and derivative thereof to preparation of antineoplastic drug
09/25/2012US8273895 NK1 antagonists
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 646